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Abstract
Inflammatory bowel disease (IBD) is a group of diseases that affect the gastrointestinal
tract. Environmental factors, such as smoking, have been shown to play a role in the
development of IBD; however, minimal research regarding secondhand smoke (SHS)
exposure and the development of IBD has been conducted. The purpose of this study
was to examine whether there was a relationship between childhood SHS exposure and
the development of IBD. Bronfenbrenner’s ecological systems theory was used in this
study as a basis that the environment can aid in the development of disease. The research
questions addressed the potential association between childhood SHS exposure and IBD
development as well as the association between childhood SHS exposure and the age at
diagnosis. A quantitative, cross-sectional design was used to analyze secondary data
collected by a government organization regarding childhood SHS exposure and IBD
status as well as other demographic, genetic, and environmental factors. There were 74
participants who met the inclusion factors to be included in this study. Multinomial
logistic regression was conducted to analyze the variables in the data. The results
indicated no significant relationship between childhood SHS exposure and IBD
development as well as no significant relationship between childhood SHS exposure and
the age of diagnosis. The results of this research can be used to inform future studies
regarding the association of SHS exposure and IBD and possibly increase knowledge
regarding individual risk factors for IBD and how physicians diagnose and treat patients.
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Chapter 1: Introduction to the Study
Introduction
Inflammatory bowel disease (IBD) is a group of autoimmune, inflammatory,
digestive diseases that consist of ulcerative colitis (UC) and Crohn’s disease (CD)
(Crohn’s and Colitis Foundation [CCF], 2014; Moran, 2017). UC can result in
inflammation of the colon, while CD can result in inflammation throughout the entire
digestive tract (CCF, 2014; Moran, 2017). The age of diagnosis for the development of
UC and CD is between 15 and 35 years old, although disease diagnosis can occur at any
age for either disease (CCF, 2014; Moran, 2017). The exact causes of UC and CD are
not entirely known (CCF, 2014; Moran, 2017). Hereditary, genetic, and environmental
factors can facilitate the development of CD, while genetics, the immune system, and the
environment can play a part in the development of UC (CCF, 2014; Moran, 2017). These
two types of IBD are common in families and affect males and females equally but affect
Whites (including Jews of European descent) more than other ethnicities (CCF, 2014,
2019b; Moran, 2017). However, CD has been shown to have a higher chance of running
in families than UC, especially if a first-degree relative has IBD (CCF, 2019a).
Examination of environmental factors has shown that IBD occurs more in developed
countries, urban areas, and northern climates when compared to undeveloped countries,
rural areas, and southern climates (CCF, 2014). IBD might be associated with foreign
substances in the environment that might trigger the immune response but not inactivate
the immune response at the appropriate time (CCF, 2014). A combination of a viral or
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bacterial infection and the immune system response not being correctly regulated may
also cause IBD (CCF, 2014).
Smoking is an environmental factor that is associated with IBD. Smoking has
been seen to be a protective factor for UC development in adults (Lunney et al., 2015). A
protective factor is a characteristic that might help prevent the development of a disease
(Substance Abuse and Mental Health Services Administration, 2018). This means that
smokers are less likely to develop UC (Lunney et al., 2015). Conversely, smoking has
been seen as detrimental to CD development in adults, meaning that smokers are more
likely to develop CD (Lunney et al., 2015). The effect of secondhand smoke (SHS)
exposure on the development of IBD has not been thoroughly analyzed. The published
literature does not show the effect of SHS exposure during childhood on the development
of IBD (Özbeyli et al., 2017). I conducted this study to fill in this gap by focusing on the
development and diagnosis of IBD and the association with exposure to SHS during
childhood.
The problem introduced above is meaningful because it will help fill a gap in the
current literature. Researchers have examined the effect of smoking on the development
of UC and CD. Logically, the next step might be to explore the possible effects that SHS
exposure can have on the development of IBD since SHS exposure is known to be
harmful to individuals. It is crucial to examine the effect of SHS exposure during
childhood on the development of IBD to determine if the same effect exists when
exposed to active smoking. The results of this study could help in the determination of
additional factors that might cause IBD since the exact causes are still unknown even
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though it is known that the causes are multifactorial. The findings of this study can
positively affect public health by providing additional information regarding IBD that
could be used to help promote better diagnostics and further research, which may one day
lead to a cure.
In this chapter, I explain the background of IBD and smoke exposure as well as
highlight the gap in the literature regarding the lack of research on childhood SHS
exposure and IBD. The problem statement, purpose of the study, research questions, and
hypotheses are discussed. The theoretical framework and the nature of the study are also
introduced. Lastly, I address the assumptions, scope and delimitations, limitations, and
significance of this study.
Background
IBD research remains an understudied topic, but the amount of research
evaluating characteristics of IBD has increased over the years. However, some areas of
IBD research, such as pediatric research, are limited, with few studies examining this
group. Therefore, research on adults marks the possible outcomes within children, but
more research needs to be conducted with IBD and children since they are more
vulnerable than adults.
The literature has shown that cigarette smoking may have a protective effect on
the development of UC because smokers are less likely to develop UC compared to
nonsmokers (Daniluk et al., 2017; Özbeyli et al., 2017). However, smoking tends to have
a detrimental effect or association with CD because smokers are more likely to
development CD compared to nonsmokers (Daniluk et al., 2017). Smoking is also
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associated with disease progression, determination of surgery, and its outcomes for both
UC and CD (Lunney et al., 2015).
The experiences and environments that a child encounters and lives in during
early life can have an impact on their risk of developing UC and CD; the environment
includes exposure to smoke through SHS (Guo et al., 2014). The trend of pediatric cases
of IBD has been increasing, so it is only logical that the environment (such as SHS
exposure) would be a good starting point to assess for associations between SHS
exposure and IBD development in children as well as with a variety of other factors
(Benchimol et al., 2017).
The purpose of this study was to examine the association between childhood SHS
exposure, the development of IBD, and the age of diagnosis. Earlier research did not
focus on the association between childhood SHS exposure and the development and
diagnosis of IBD. If the results are statistically significant, then there may be an
association between childhood SHS exposure and the development of IBD as well as an
association between childhood SHS exposure and the age of diagnosis for those
diagnosed with IBD.
Problem Statement
The purpose of this study was to examine the association between childhood SHS
exposure, the development of IBD, and the age of diagnosis. Smoking has decreased
within the past decade; however, the number of younger individuals diagnosed with UC
and CD have increased (Benchimol et al., 2017; Centers for Disease Control and
Prevention [CDC], 2018c; Moran, 2017). Due to the decrease in the number of smokers,

5
the amount of SHS exposure has also decreased since active smoking leads to passive
smoke exposure (CDC, 2017). Based on the associations of active smoking and IBD
development, the literature has shown that UC and CD may have an inverse relationship
with SHS exposure (Lunney et al., 2015). Specifically, active smoking has shown a
decrease in UC cases and an increase in CD cases (Lunney et al., 2015). It is reasonable
to believe that a similar inverse relationship exists between SHS exposure and IBD
development. In this study, I further examined the relationship on the development of
these two IBDs and SHS exposure since only minimal research has been conducted on
this specific association.
Purpose of the Study
In this study, I evaluated this gap in public health concerning the relationship
between childhood SHS exposure and IBD development using a quantitative approach.
Secondary data with childhood SHS exposure and disease diagnosis of patients (i.e., UC,
CD, or no IBD disease) were used to examine this association. This potential association
was further addressed using the variable of age at diagnosis. The primary independent
factor analyzed was childhood SHS exposure (i.e., exposed or not exposed). The
dependent factors examined were disease diagnosis (i.e., UC, CD, or non-IBD) and age at
diagnosis (i.e., grouped into three categories based on the Montreal classification: 16
years old and younger, 17–40 years old, and over 40 years old). I controlled for
demographic variables (i.e., sex and race), genetic-related variables (i.e., relatives’ IBD
disease diagnosis), and environment-related variables (i.e., place of residence during
childhood, were you breastfed as infant, daycare attendance as a child, having pets
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growing up, were you born via C-section, were you born prematurely, and did you take
antibiotics before age 1).
Research Questions and Hypotheses
RQ1: What is the association between childhood SHS exposure and the
development of IBD after controlling for demographic (i.e., sex and race),
genetic, and environmental factors?
H01: There is no statistically significant association between childhood
SHS exposure and the development of IBD after controlling for
demographic, genetic, and environmental factors.
Ha1: There is a statistically significant association between childhood SHS
exposure and the development of IBD after controlling for demographic,
genetic, and environmental factors.
RQ2: What is the association between childhood SHS exposure and the age at
diagnosis for those who have IBD after controlling for demographic (i.e., sex and
race), genetic, and environmental factors?
H02: There is no statistically significant association between childhood
SHS exposure and the age at diagnosis for those who have IBD after
controlling for demographic, genetic, and environmental factors.
Ha2: There is a statistically significant association between childhood SHS
exposure and the age at diagnosis for those who have IBD after controlling
for demographic, genetic, and environmental factors.
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Theoretical Foundation
The theoretical framework for this study was Bronfenbrenner’s ecological
systems theory. This theory postulates that the environments in which a child lives, as
well as the inherent qualities of that child, determine the growth and development of that
child (The Psychology Notes Headquarters, 2013). This approach consists of examining
the multiple environments (or systems) in which a child lives: microsystem (i.e.,
immediate environment), mesosystem (i.e., connections), exosystem (i.e., indirect
environment), macrosystem (i.e., social and cultural values), and chronosystem (i.e.,
changes over time; The Psychology Notes Headquarters, 2013). The microsystem
includes entities that are the most influential on the life of the child since the child
interacts with these the most; these entities include, but are not limited to, school,
daycare, and family (Paquette & Ryan, n.d.). The chronosystem consists of the element
of time and how the development of the child can change over time based on the child’s
environment and their reaction to the environment (Paquette & Ryan, n.d.). While the
theory itself consists of more environments, I focused only on the microsystem and the
chronosystem in this study.
Nature of the Study
The nature of this study was quantitative. A quantitative research method allows
for the comparison or correlation of population attributes and the generalization of results
to populations (Creswell, 2013). I developed the research questions for this study to
examine the associations between childhood SHS exposure, IBD development, and age
of diagnosis. Secondary data from the National Institutes of Health Integrative Human
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Microbiome Project: The Inflammatory Bowel Disease Multi’omics Database
(IBDMDB) were used to examine this association. Multinomial logistic regression was
used to determine the association between the independent and dependent variables. The
independent variable was childhood SHS exposure, and the dependent variables were
IBD diagnosis for RQ1 and age at diagnosis for RQ2.
Definitions
Age at diagnosis: The age (in years) at which an individual was diagnosed with
IBD through the careful examination of signs, symptoms, exams/procedures, and tests
(National Cancer Institute at the National Institutes of Health [NCI at NIH], n.d.).
Childhood secondhand smoke (SHS) exposure: Exposure during childhood to
smoke in the environment that came from another individual using tobacco products
(NCI at NIH, n.d.).
Crohn’s disease (CD): A type of IBD that can affect the entire gastrointestinal
(GI) tract, especially the small intestine and colon (CCF, 2014; NCI at NIH, n.d.).
Inflammatory bowel disease (IBD): A category of chronic inflammatory diseases
that includes CD and UC that result in inflammation of the GI tract, which can lead to
symptoms, such as abdominal pain, constipation, diarrhea, rectal bleeding, loss of
appetite, weight loss, fatigue, urgency to use the restroom, etc.; the exact cause of IBD is
unknown, and there is no known cure (CCF, 2019b; NCI at NIH, n.d.).
Ulcerative colitis (UC): A type of IBD that only affects the colon (CCF, 2014;
NCI at NIH, n.d.).
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Assumptions
I made a handful of assumptions that were essential for this study to be
conducted. First, it was assumed that the data set being used followed the characteristics
of a normal distribution due to the Central Limit Theorem, which states that a sample size
of 30 or more can be assumed to be large enough to follow a normal distribution (Kwak,
& Kim, 2017). The data set that was used contained 74 patients who met the inclusion
criteria for this study. This assumption of a normal distribution was critical in the
selection of the most appropriate statistical method to use for data analysis. There were
also limited secondary data sources available that contained the necessary variables for
the completion of this study.
Second, I assumed that the diagnosis of IBD was determined by a qualified
physician (i.e., gastroenterologist) through the use of colonoscopy and analysis of
histological samples, if relevant. This was important to assume because a self-diagnosis
based on symptoms, a diagnosis by an unqualified physician, or a diagnosis without a
colonoscopy cannot be definitive.
Scope and Delimitations
One delimitation of this study was participation in the IBDMDB. Patients also
had to meet the inclusion criteria of childhood SHS exposure and patient IBD status. If
information regarding childhood smoke exposure and development and diagnosis of IBD
(or not) were not collected, then the patients were not included in the study due to these
factors being the primary variables required for the research questions to be answered.
Due to the limited patients involved in this data set, the results of this study have a
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limited generalizability to the general population because results are only relevant (i.e.,
not statistically significant) to those individuals included.
Bronfenbrenner’s ecological systems theory aided me in the development of this
study because this theory has been used for a variety of studies regarding children and
how their environments affect disease progression over time (see The Psychology Notes
Headquarters, 2013). I considered using the concept nicotine replacement therapy for
this study; however, this concept did not quite fit the needs of this study because most
quantitative research is formed based on theory instead of a concept.
Limitations
I identified several limitations for this study. One limitation was the use of
secondary data; this can be considered a limitation since the data were not necessarily
collected for answering the specific research questions of this study, and I was not
involved in the actual collection of the data, so I do not have a clear understanding of
how the data collection process was conducted (Cheng & Phillips, 2014). Another
limitation was that the specific geographic regions where the patients live are unknown,
so I was not be able to control for the geographic area in this study. A third limitation
was not being able to examine additional variables that might be of interest, such as SHS
exposure during pregnancy, paternal versus maternal SHS exposure, and the length of
time exposed to SHS during childhood. These variables could potentially be addressed in
future research because they were not available for analysis within the chosen data set. A
final limitation was the small sample size; this could not be prevented because there are
limited data available that directly relates to the research questions. However, the Central
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Limit Theorem states that the number of patients available is sufficient enough (Kwak &
Kim, 2017).
Significance
Research for IBD has increased in the past years, but there is still less research
being conducted for this disease when compared to some other conditions that may affect
a greater percentage of the population, such as cancer. The findings of this study fill the
gap in the literature regarding whether SHS exposure during childhood is associated with
IBD development. The results from this study, partnered with those of previous
researchers, may allow public health professionals to be able to predict whether IBD
would develop based on childhood characteristics, such as the environment (i.e., SHS
exposure, attending daycare, having pets, etc.) and other influences (i.e., breastfed as an
infant, born via C-section, born prematurely, and treated with antibiotics before the age of
1). This knowledge could lead to better treatment methods and more significant
preparation for treatment in individuals because the findings of this study may lead to
future research that may pinpoint which individuals are at a higher risk for developing
IBD.
The results of this study might also lead to future studies that evaluate additional
risk factors for the development of IBD. The ability to determine an individual’s risk for
developing a disease is an essential aspect of epidemiology (CDC, 2006). At the
individual level, knowing the personal risk of disease can lead to individuals taking
preventive actions to eliminate or reduce their risk of developing the disease. At the
community level, policies can be enacted, which may help prevent the development of
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IBD and focus on increasing public health regarding GI diseases. At the clinical level,
additional risk factors can be evaluated, which may help physicians better diagnose and
treat the health of the public with IBD.
Summary
Even though research involving IBD has increased over the years, the association
between childhood SHS exposure and the development and diagnosis of IBD has not
been adequately examined. In this chapter, I provided the background of IBD and
smoking to create a platform from which to expand research to childhood SHS exposure
and IBD development and diagnosis. This critical research was introduced and supported
by providing an overview of previous related literature. The problem statement and
purpose of the study were discussed. I also presented the research questions and
hypotheses as well as the theoretical foundation, nature of the study, essential definitions,
assumptions, scope and delimitations, limitations, and significance.
In Chapter 2, I will provide a detailed review of current and previous literature
related to the research questions and topic as well as specify the gap that this research
study aimed to fill. Topics discussed will include a background of IBD development and
diagnosis, the observed associations between active smoking and IBD development,
research involving children and IBD, and analysis concerning the theoretical foundation
of the study.
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Chapter 2: Literature Review
Introduction
IBD is a group of chronic, autoimmune diseases that affect over 3 million people
(CCF, 2014). Within the past decade, more children have been diagnosed with IBD than
previous decades (Benchimol et al., 2017; Moran, 2017). Since smoking is associated
with the development of IBD, it is crucial to examine the effects of SHS on the
development of IBD in children (Lunney et al., 2015). Of what is known of the
associations seen between IBD and smoking, it is reasonable to believe that SHS
exposure will have the same effect on IBD, meaning that secondhand smoking will have
a protective effect on UC and be detrimental to CD development (Lunney et al., 2015).
Because the number of younger individuals being diagnosed with IBD has
increased while smoking has decreased, the purpose of this study was to examine the
association between childhood SHS exposure, the development of IBD, and the age of
diagnosis. There is limited research regarding the association of SHS exposure and the
development of IBD in children; therefore, I examined this potential association in this
study to try to gain some insight regarding these variables, which could lead to a better
understanding of SHS and early life exposure and its potential role in the development of
IBD in children. This study could be an essential step in determining possible causes of
these diseases because their origins are not entirely known (see CCF, 2014).
In this literature review, I sought to examine the basis for the intended association
for this research. In this chapter, I examine Bronfenbrenner’s ecological systems theory
and the reasoning behind why this theory is acceptable to use for this association. The
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key factors that may play a role in the association between childhood SHS exposure and
the development of IBD are also identified and explored. I expound upon what is known
regarding IBD, including the relationship between smoking and IBD development in
adults and other childhood or early-life exposures, in an attempt to provide the
information needed to proceed with the current study.
Literature Search Strategy
I located the extant literature for this review through searches of the following
databases: MEDLINE and CINAHL combined, EBSCO, PubMed, Science Direct, and
Google Scholar. The focus was on literature published in the last 5 years, but some
pertinent information had to be obtained from older documents. The keyword search
terms used included inflammatory bowel disease, IBD, ulcerative colitis, UC, Crohn’s
disease, CD, children, childhood exposures, smoking, secondhand smoking,
Bronfenbrenner’s ecological systems theory, disease, and several combinations of these
terms.
Theoretical Foundation
Since this study was involved with the development of a disease based on
childhood exposures, I used Bronfenbrenner’s ecological systems theory as the
theoretical foundation. Bronfenbrenner first authored this theory in a book, The Ecology
of Human Development: Experiments by Nature and Design, published in 1981.
However, Bronfenbrenner developed the ecological systems theory mostly in 1979 with
the addition of the chronosystem in 1986, partly based on the author’s influence on and
participation in the Head Start Program (“Ecological systems theory,” 2018).
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Bronfenbrenner (1981) stated that the environment plays a crucial role in the growth and
development of a child, including the development of disease. There are five levels of
the environment in which a child lives: microsystem, mesosystem, exosystem,
macrosystem, and chronosystem (“Ecological systems theory,” 2018).
Bronfenbrenner’s ecological systems theory is based on the premise that the
interaction of the child and these five environments influence the child’s development
(“Ecological systems theory,” 2018). While this theory does not provide real solutions to
health problems, the examination of these five different environmental systems can lead
to determining the potential cause of a health problem since all possible variables are
examined throughout all the systems (“Ecological systems theory,” 2018). The
microsystem consists of the child and all of his or her interactions with family members,
friends, and other relevant individuals, such as teachers, who together encompass the
child’s immediate environment (“Ecological systems theory,” 2018; Paquette & Ryan,
n.d.; The Psychology Notes Headquarters, 2013). The microsystem can also affect the
development of the child’s habits and temperaments, which may stay with him or her for
life (“Ecological systems theory,” 2018). The mesosystem represents the connections or
relationships between the child’s different microsystems, such as parents and teachers
interacting (“Ecological systems theory,” 2018; The Psychology Notes Headquarters,
2013). The exosystem involves the child’s indirect environment, which can affect the
child and his or her microsystem, but the child does not influence it (“Ecological systems
theory,” 2018; The Psychology Notes Headquarters, 2013). The exosystem can include
the neighborhood, the local community, and health and social services as well as local
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businesses and media (“Ecological systems theory,” 2018). The macrosystem consists of
the culture/subculture, social class, ethnic group, and religious affiliations that surround
the child (“Ecological systems theory,” 2018; The Psychology Notes Headquarters,
2013). These entities may change over time, and the child may play a small part in these
changes; the changes can affect the child’s values and beliefs (“Ecological systems
theory,” 2018). The outermost level, the chronosystem, includes the element of time and
how the development of the child can change over time based on the child’s environment
and their reactions to and interactions with the environment (“Ecological systems
theory,” 2018; Paquette & Ryan, n.d.; The Psychology Notes Headquarters, 2013).
This theory has been used previously in social work, education, psychology,
policymaking, and public health (“Ecological systems theory,” 2018). Zhou and Cheah
(2015) examined the possible health risks that may lead to obesity in Chinese American
children using this theory since this population is typically left out of the obesity
equation; the authors created a pathway that may help further research for this population.
Graves and Sheldon (2017) used Bronfenbrenner's ecological systems theory to highlight
the potential components that can lead to effective recruitment methods for African
American youth as well as barriers that may stem from the youths’ interactions with these
systems. Additionally, Kekoni, Miettinen, Häkälä, and Savolainen (2019) studied the
factors affecting child development in foster care using this theory to determine why
foster children tended to not succeed as well in adulthood compared to those not in foster
care. However, I found no articles regarding one specific environmental factor, such as
SHS exposure, and the development of the disease.
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Bronfenbrenner’s ecological systems theory focuses on how the environment on
all levels can affect the growth and development of a child, including the development of
disease or other health conditions (Paquette & Ryan, n.d.). In this study, I examined the
relationship between childhood SHS exposure and the development of IBD due to this
environmental exposure. This theory has also been used to highlight the importance of
considering all potential environmental factors because any factor could have a possible
effect on the child’s life and, more specifically, health (“Ecological systems theory,”
2018). I developed RQ1 to inquire whether childhood SHS exposure could be associated
with the development of IBD. Additional environmental factors were taken into
consideration as possible covariates to ensure that any association seen was from
childhood SHS exposure alone. RQ2 addresses if there is a relationship between SHS
exposure and age of diagnosis while also considering other environmental factors that
could affect any potential associations. The levels of the environment that were
examined in this study were the microsystem and chronosystem. Only these two levels
were considered because any possible SHS exposure would only be relevant if it was
continuous, meaning that it would have to happen around the child often, so it makes
sense that the exposure would occur in the child’s immediate environment (i.e.,
microsystem), and then the disease outcome is what happens over time (i.e.,
chronosystem).
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Literature Review Related to Key Variables
Inflammatory Bowel Disease (IBD)
IBD is a type of classification for the two primary diseases it encompasses: UC
and CD (CCF, 2014). Both of these diseases result from inflammation in the GI tract
(CCF, 2014). UC involves only inflammation of the colon and sometimes the rectum,
whereas the inflammation involved in CD can appear in any part of the GI tract from the
mouth to the anus (CCF, 2014; Gajendran, Loganathan, Catinella, & Hashash, 2018).
UC tends to cause inflammation in a particular section, and it is continuous (CCF, 2014).
In contrast, there can be alternating affected (i.e., inflamed) and nonaffected areas for CD
(CCF, 2014). This difference between the appearance of UC and CD allows for doctors
to evaluate and diagnose UC based solely on colonoscopy results partnered with
symptoms and histological samples (if taken or if available).
Causes
Researchers do not entirely understand the mechanisms behind the development
of IBD; the causes are understood to be a combination of hereditary factors, genetics, the
immune system responses, and the environment (CCF, 2014). Gajendran et al. (2018)
stated that CD risk factors include smoking, low fiber-high carbohydrate diet, altered
microbiome, and medications such as nonsteroidal anti-inflammatory drugs.
Genetics play a role in the development of IBD; if an individual has a first-degree
relative with IBD, then that individual is 10 times more likely to develop IBD compared
to those individuals without a first-degree relative with IBD (Orholm et al., 1991). Five
to 20% of IBD patients have a first-degree relative with IBD (CCF, 2014). Those
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individuals with a second degree relative with IBD also have an increased risk of
developing IBD, but it is a lot lower than with a first-degree relative (Orholm et al.,
1991). Children who have mothers with CD have an increased risk of developing CD,
especially if the mother was over the age of 35 years old and a smoker (Orholm et al.,
1991). According to Mikhailov, Christensen, and Furner (2017), family history of UC is
a risk factor for the development of CD, but a family history of CD is a protective factor
for the development of CD.
Conflicting information regarding whether diet influences the development of
IBD has been observed in research, but more research is needed to determine the exact
contribution that diet may or may not have on the development and progression of IBD
(CCF, 2014). Voutilainen et al. (2018) examined the relationship between early life
exposures and the development of IBD later in life (within a 34-year follow-up period).
Low high density lipoprotein cholesterol levels during childhood were correlated with the
development of IBD; an inverse relationship between c-reactive protein concentrations
during childhood and the development of IBD was also observed (Voutilainen et al.,
2018). Diets high in sucrose before diagnosis have been associated with a higher risk of
IBD development (Reif et al., 1997). An increase in the risk of UC was associated with
high amounts of trans-unsaturated fats, while a decrease in the risk of UC was associated
with high amounts of dietary long-chain n-3 polyunsaturated fatty acids
(Ananthakrishnan et al., 2014).
IBD involves the patient’s immune response continuing long after it should stop
because it misclassifies food, bacteria, and other substances as foreign and, therefore,
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proceeds to attack the healthy cells, which causes inflammation (CDC, 2018b). Changes
in gut microbiota can lead to nonspecific gut inflammation, which can lead to IBD in
those individuals with genetic susceptibility (Abegunde, Muhhamad, Bhatti, & Ali,
2016).
However, it is possible that medications can affect IBD development. Antibiotic
exposure has been seen to be associated with new CD development but not UC (Ungaro
et al., 2014). Disease activity is not altered by oral contraceptives (Cosnes, Carbonnel,
Carrat, Beaugerie, & Gendre, 1999). A 3 times increase in flares was observed with CD
patients who continued to take oral contraceptives, but smoking could also be a
confounding variable (Timmer, Sutherland, & Martin, 1998).
Impact of IBD on Individuals’ Lives
The age of diagnosis for UC and CD tends to correlate with the reproductive ages
of 15 to 30 years old (CCF, 2014). However, more pediatric patients are being diagnosed
with these diseases at even younger ages, which can have an extreme impact on their
developmental stages (Benchimol et al., 2017; Moran, 2017). A child’s height can be
stunted or slowed as a result of developing one of these diseases during childhood;
delayed puberty is also possible (CCF, 2014).
Symptoms of IBD include constipation, diarrhea, the urgency to use the
bathroom, not knowing whether you will make it to the toilet in time, gas, abdominal
pain, rectal bleeding, loss of appetite, fatigue, etc. (CCF, 2014). Childhood is such a
critical time in an individual’s life with their bodies growing and developing, and
children are susceptible to other problems, such as emotional issues (i.e., embarrassment,
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lack of understanding) associated with these diseases (CCF, 2014). There is no known
cure for IBD, so a lifetime of care is needed; when this starts at such an early age, it can
be detrimental to the quality of life of the child (Abegunde, Muhammad, & Ali, 2016).
The length of time since diagnosis can also determine the probability that a patient will
require surgery for the disease. For patients with UC, up to one third will require surgery
after living with the disease for 30 years (CCF, 2014). For patients with CD, about 70%
will require surgery at some point in their lifetime (CCF, 2014). Thirty percent of these
CD patients who undergo surgery will have a recurrence of CD within 3 years because it
is possible for CD to come back in parts of the digestive tract that were not removed
during surgery (CCF, 2014).
In addition to living with IBD, some additional health concerns may accompany
the disease. Mikhailov et al. (2017) found that patients with IBD were more likely to
have other illnesses, respiratory diseases, or hospitalizations during infancy than non-IBD
patients. IBD patients are also more likely to have the following chronic conditions:
heart disease, lung disease, cancer, diabetes, arthritis, kidney disease, any liver disease,
and ulcers compared to those without IBD (CDC, 2018a).
Anemia. Anemia is an extraintestinal manifestation that is very common in IBD
patients (Hindryckx, Amininejad, Van De Vijver, & Bossuyt, 2014). Anemia in IBD
patients can be caused by a multitude of mechanisms including blood loss from inflamed
intestinal tissue, nutrient deficiency of iron and B12, chronic inflammation, hemolysis,
and myelosuppression from medications (Dieleman & Heizer, 1998).

22
Venous thromboembolism. It was found that IBD patients are 3.5 times more
likely to develop venous thromboembolism compared to sex- and age-matched controls
(Novacek et al., 2010). This increased risk could result from a combination of
malnutrition, heredity factors, surgery and hospitalization, and inflammation from the
disease (Magro, Soares, & Fernandes, 2014; Novacek et al., 2010).
Heart conditions. The risk for developing hypertension correlates with an
increase in obesity and metabolic syndrome as well as the use of medications such as
corticosteroids and cyclosporine (Seminerio et al., 2015). IBD is also associated with
increased risks for several heart conditions such as atrial fibrillation, stroke, myocardial
infarction, heart failure, and cardiovascular-related death during a flare; there are no
elevated risks for these heart conditions during remission (Kristensen et al., 2014). The
risk of coronary artery disease is slightly higher for IBD patients (Singh, Kullo, Pardi, &
Loftus, 2015; Singh, Singh, Loftus, & Pardi, 2014). In IBD patients, young adults (less
than 50 years old) and women have a higher risk of cardiovascular disease compared to
older adults (more than 50 years old; Singh et al., 2014).
Osteoporosis. Osteoporosis is another extraintestinal complication for IBD
patients (CCF, 2014). The easiest way to prevent osteoporosis in patients is to reduce the
number of glucocorticoids taken (Abegunde, Muhammad, & Ali, 2016).
Sleep deprivation/disturbances. Sleep problems have been associated with IBD
(Dickstein & Moldofsky, 1999). Sleep disorders can greatly affect the quality of life for
those with IBD (Abegunde, Muhammad, & Ali, 2016). Sleep disturbances can also be
caused by the medications taken, such as corticosteroids (CCF, 2014). There is not
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enough data to mandate treating sleep disorders in IBD patients, but IBD patients should
be screened for sleep disorders (Abegunde, Muhhamad, Bhatti, et al., 2016).
Additional medical conditions. Other extraintestinal complications include
redness, pain, and itchiness of the eyes; mouth sores; joint pain and swelling; tender
bumps, painful ulcerations, and other sores/rashes of the skin; kidney stones; and primary
sclerosing cholangitis, hepatitis, and cirrhosis of the liver (CCF, 2014).
Vaccination. Vaccination is another aspect of health that is even more important
for individuals with IBD. Since IBD patients usually have compromised immune
systems due to medications, these patients must be vaccinated to protect them against
vaccine-preventable diseases (Chaudrey, Salvaggio, Ahmed, Mahmood, & Ali, 2015;
Reddy, Beavers, Hammond, Lim, & FalckYtter, 2015). Live vaccines are not
recommended as there is an increase in infection for immunocompromised IBD patients
(Chaudrey et al., 2015; Reddy et al., 2015). All other vaccines should be given before
beginning immunosuppressive therapy medications, if possible (Chaudrey et al., 2015;
Reddy et al., 2015). Exposure to live vaccines through family members is also a concern
as it places the patient at risk (Chaudrey et al., 2015; Reddy et al., 2015). However, there
are some circumstances (such as traveling to foreign countries) when live vaccines may
be required, or the benefits outweigh the risks, but it is crucial to speak with a doctor to
determine the best time to receive a live vaccine (Chaudrey et al., 2015; Reddy et al.,
2015).
Psychology and psychiatry. There may be a psychological component of IBD
that can affect the patient's well-being and social life. This may be due to how an
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individual perceives him or herself as being functionally disabled due to having this
chronic disease (Irvine et al., 1994; Turnbull & Vallis, 1995). Also, the chronic nature of
IBD with alternating stages of remission and flares, along with medication side effects,
can lead to a person feeling alone and depressed (CCF, 2014). IBD patients are also
more likely to experience higher amounts of psychiatric distress, anxiety, alexithymia,
and somatosensory amplification (Becker et al., 2015). Due to this, relationships with
friends, family members, or intimate partners can be negatively affected and result in a
lower quality of life for the patients (Becker et al., 2015). Also, stress has been
associated with an increase of flares in IBD but not an increase in risk for developing
IBD (Gerbarg et al., 2016).
Treatments and Care
Unfortunately, there is no known cause for these diseases, but research shows that
the causes of these diseases stem from genetic, environmental, and immune system
components (CCF, 2019a, 2019c). Those individuals with an immediate family member
with an IBD are more likely to develop IBD as well (5% to 20% with IBD have a firstdegree relative with IBD) compared to individuals without a family history of IBD (CCF,
2014). Those individuals whose parents have been diagnosed with IBD have an even
higher percentage of developing and being diagnosed with IBD (CCF, 2014).
Care for IBD patients is more focused on controlling symptoms rather than
preventing further disease (Abegunde, Muhammad, & Ali, 2016). Including preventive
measures may help make the individual’s life more bearable, help plan for what might
happen, and help catch new signs of disease or complications earlier than without
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preventive health care. Preventive care could also lead to better options for patients since
the disease could be detected earlier, and the disease may be in a less aggressive state.
Steroids are commonly used to try to induce remission in IBD patients, but they
are not effective in maintaining remission (Abegunde, Muhammed, & Ali, 2016). Side
effects of steroids can be adverse, so limiting the amount of steroid use in IBD patients is
essential (Abegunde, Muhammed, & Ali, 2016). Probiotics, in general, have not been
effective in managing IBD (Sokol, 2014). However, VSL#3 is effective at inducing
remission in patients with mild-to-moderate active UC (Sokol, 2014). VSL#3 has also
been seen to be beneficial in UC patients who have undergone ileal pouch-anal
anastomosis (Singh, Stroud, Holubar, Sandborn, & Pardi, 2015). VSL#3 is a mixture of
Lactobacillus casei, L. plantarum, L. acidophilus, B. breve, B. infantis, Bifidobacterium
longum L.delbrueckii subsp. bulgaricus, and Streptococcus salivarius
subsp.thermophiles, which tends to work better than only single agents/bacteria (Sokol,
2014). Additional medications used for the treatment of IBD include 5-aminosalicylic
acids, thiopurines, methotrexate, anti-TNF-alpha agents, and anti-integrin antagonists.
With all of these medications, routine lab testing should be conducted to ensure main
body systems (liver, kidney, etc.) are not negatively affected by the medicines.
Smoking cessation can be seen as a treatment for those with CD as smoking
worsens CD (Abegunde, Muhammad, & Ali, 2016). Smoking cessation reduces the risk
of CD, disease flares, surgeries, and the number of treatments or medications needed for
an individual (Nunes et al., 2016). Smoking cessation is not considered a treatment for
UC since smoking is a protective factor for UC, but smoking cessation is considered
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crucial due to the other disastrous effects smoking has on the human body and its position
as a risk factor for a multitude of other diseases (Abegunde, Muhammad, & Ali, 2016).
Nunes et al. (2016) stated that it is essential for gastroenterologists and primary care
physicians to advise their IBD patients who smoke to quit smoking as the number of
disease relapses (i.e., flares) is less in nonsmokers and those who quit smoking compared
to current smokers.
Moderate exercise might help relieve some of the IBD symptoms as well as
decrease the risk of obesity (Melinder et al., 2015). Exercise and physical fitness have
been seen to have an inverse relationship with IBD activity, which points to a protective
effect of exercise on IBD (Melinder et al., 2015). Physical activity can help improve the
quality of life for IBD patients by reducing disease activity; this can make physical
activity an essential part of therapy/treatment for advancing all facets of IBD patient
health (Bilski, Brzozowski, Mazur-Bialy, Sliwowski, & Brzozowski, 2014; Klare et al.,
2015). Diet-based interventions have not been successful in maintaining remission in
IBD (Ballegaard et al., 1997; González-Huix et al., 1993).
Smoking and Health in General
Smoking is “the leading cause of preventable death” worldwide (CDC, 2019,
para. 2). Smoking affects almost every system in the body and is well-known for its risks
of cardiac, respiratory, and oncologic diseases (Abegunde, Muhammad, & Ali, 2016;
Siquiera, 2017; CDC, 2019).
Smoking can result in appetite suppression and thus weight loss, but this can turn
into smokers gaining weight with increased fat deposits and decreased metabolic rates for
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chronic conditions (long-term smoking; Siquiera, 2017). Nicotine can negatively affect
fertility for both men and women and possibly lead to erectile dysfunction; smoking also
has been seen to have adverse reactions during pregnancy resulting in reduced weight,
length, and head circumference of the fetus which can lead to long-term effects such as
obesity, hypertension, Type 2 diabetes, respiratory dysfunction, neurobehavioral effects,
and impaired fertility as well as “significant impairments in cognitive functioning,
impulsivity, hyperactivity, an increased risk of developing an addiction disorder” (Bruin,
Gerstein, & Holloway, 2010; Siquiera, 2017, p. e7).
Secondhand Smoking and Health in General
Nicotine (the addictive ingredient) is one of the significant components released
through smoking and other tobacco products. Children can be introduced to nicotine
through all types of tobacco products, including chewing tobacco, cigarettes, pipe
tobacco, nicotine gum and patches, some insecticides, and now e-cigarettes (Siquiera,
2017). If vomiting is induced as a result of these products, then the effects are not severe
due to the toxins exiting the body (Siquiera, 2017). However, e-cigarettes have nicotine
in a liquid form which is more easily taken in a concentrated dose, and, if ingested, this
can lead to death in children from nicotine poisoning (lethal at levels between 1 and 13
mg/kg for children and as little as 50 to 60 mg/kg in adults; Siqueira, 2017). Symptoms
of nicotine ingestion range from vomiting and nausea to arrhythmias and coma (Siqueira,
2017).
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Association Between Smoking and IBD Development
Research has been conducted regarding active smoking and its association with
IBD development. Smoking has been seen to have a protective effect on the
development of UC and a detrimental effect on the development of CD (Daniluk et al.,
2017). This means that smokers are less likely to develop UC but more likely to develop
CD; nonsmokers are at a higher risk of developing UC and a lower risk of developing
CD. The protective factor of smoking on UC is very unusual as smoking is typically
detrimental to all body systems. Also, smoking is usually a risk factor for the
development of several diseases and health conditions. Patients with UC, who are
current smokers, are more likely to experience a less severe disease course, require fewer
steroids and other medications, and require fewer hospitalizations (Mokbel, Carbonnel,
Beaugerie, Gendre, & Cosnes, 1998). Those individuals who quit smoking before
disease onset had higher hospitalizations for colectomy (i.e., surgery; Boyko, Perera,
Koepsell, Keane, & Inui, 1988). Current smokers have lower relapse rates and colectomy
occurrences compared to nonsmokers (Boyko et al., 1988).
On the contrary, smoking can have a negative effect on the development of CD
(Abegunde, Muhammad, & Ali, 2016). Mikhailov et al. (2017) evaluated several smoke
exposures, with many of them acting as risk factors for the development of CD; a
combination of all smoke exposures was continuously seen as a significant risk factor for
the development of CD. Mikhailov et al. consistently found that any amount of smoke
exposure was associated with the development of CD. The lack of research regarding
SHS exposure and IBD development is what has led to this current research study.
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Other Childhood Exposures and IBD Development
Environmental factors can also contribute to the development of IBD and can
encompass a variety of avenues. For example, early-life indicators, such as the place
where you were born or lived (in the United States or outside the United States; rural,
urban, or suburban; hospital or not) could affect IBD development. Other early
influences or factors such as breastfeeding can play a part in the immune response; this is
still classified as an environmental exposure as it is a factor being introduced to the
individual from outside of the body. Something as simple as whether the child was
exposed to having a pet in the house could also affect the development or
nondevelopment of IBD. There is a multitude of influences or factors that can impact the
potential of future disease development. SHS exposure is an environmental factor for
which I have not found any data, but it is possible that this could be associated with the
development of IBD as well.
There are conflicting results regarding breastfeeding and association with IBD;
some studies say that breastfeeding is protective while others say there is no association,
and, still, others name breastfeeding as a risk factor for IBD development (Ekbom,
Adami, Helmick, Jonzon, & Zack, 1990). Guo et al. (2014) found that those individuals
with CD who were breastfed were less likely to have surgery related to their disease
while those individuals who experienced childhood SHS exposure were more likely to
have to undergo CD-related surgery. These associations were correct when controlling
for age at diagnosis, disease duration, location of disease, disease behavior, the presence
of perianal disease, and current smoking status (Guo et al., 2014). However, when
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examining the influences of breastfeeding and SHS exposure simultaneously, only
breastfeeding was found to be significant and associated with a decreased risk of diseaserelated surgery (Guo et al., 2014). On the contrary, Mikhailov et al. (2017) found no
statistically significant association between being breastfed as an infant and the
development of CD; however, a nonsignificant protective effect was observed with
breastfeeding and the development of CD. Additionally, a longer duration of
breastfeeding tended to have a more significant protective effect on the development of
CD (Mikhailov et al., 2017).
Being diagnosed at an older age was associated with less risk of surgery for CD
while having pets, growing up on a farm, or going to daycare were not associated with
risk for CD-related surgery (Guo et al., 2014). Guo et al. (2014) found no association for
risk of UC-related surgery when examining early life exposures.
Some research suggests that vitamin D may play an active role in disease activity
for IBD (Basson, Swart, Jordaan, Mazinu, & Watermeyer, 2016; Del Pinto, Pietropaoli,
Chandar, Ferri, & Cominelli, 2015; Holmes, Xiang, & Lucas, 2015). However, there are
conflicting results about vitamin D and its potential effect on IBD development and
disease course. Geographic location was suggested by some to be a factor of IBD
development. Those living in more northern latitudes have a higher incidence of IBD
compared to southern latitudes due to different amounts of exposure to UV light (Del
Pinto et al., 2015; Holmes et al., 2015); others have not seen this relationship. While
more information is needed to determine the extent of the association of vitamin D
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deficiency and IBD, it is essential to test levels of vitamin D in IBD patients (Abegunde,
Muhammad, Bhatti, et al., 2016).
Summary and Conclusions
The exact nature of IBD origins has not been identified. However, it is known
that the environment, genetics, and immune system response all play a part in the
development of IBD. The diagnosis of IBD forever changes the life of an individual; this
includes the individual being more susceptible to other diseases or health conditions as
well as the individual's social life. There is no known cure for IBD, although there is a
wide range of treatments from antibiotics to immunosuppressants to biologics to surgery.
Smoking is an environmental factor that has been continuously examined with
regards to IBD. Smoking has been associated with IBD development and disease
progression, with smoking being detrimental for CD development but protective against
UC development. However, SHS exposure on the development of IBD in children has
not been thoroughly examined. This current study aims to lessen this gap by examining
the relationship between disease diagnosis and childhood SHS exposure. Conducting this
research may lead to more knowledge regarding early life exposures and IBD diagnosis.
In Chapter 3, I will describe the research design and rationale, methodology, and threats
to validity for this study.

32
Chapter 3: Research Method
Introduction
The cause of IBD is known to be multifactorial; even though the exact specifics
are still unknown, the environment is one of the critical factors in IBD development
along with genetics and the immune system response (CCF, 2014; Moran, 2017). With
the environment factoring into the causal equation, it is crucial to investigate early life
exposures, especially when individuals are diagnosed during childhood. One specific
environmental, early-life exposure comes from the introduction to SHS during childhood.
While research exists regarding smoking and IBD development in adults, little is known
regarding childhood SHS exposure and the development of IBD in children. Evaluating
this potential relationship could lead to insights regarding whether SHS exposure has the
same effect on the development of IBD as smoking does. In this chapter, I describe the
research design and rationale, methodology, and threats to validity for this study.
Research Design and Rationale
Quantitative research methods involve the gathering and managing of numerical
data to describe a phenomenon and be able to generalize it to a broader population (USC
Libraries, 2019). Quantitative research aims to evaluate the relationship between two or
more variables using numerical data and statistical tests (USC Libraries, 2019).
Quantitative research can be either descriptive/observational or experimental depending
on what type of data are collected; observational studies aim to evaluate the relationship
or associations between variables, while experimental studies aim to determine causality
between the variables (USC Libraries, 2019). In this current study, I conducted an
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observational study in which the relationship between childhood SHS exposure and IBD
development was evaluated. The independent variable was childhood SHS exposure,
while the dependent variable for RQ1 was the disease diagnosis of patients and the
dependent variable for RQ2 was the age at diagnosis. Additional covariates in this study
were demographic variables (i.e., sex, race), genetic-related variables (i.e., relatives’ IBD
disease status), and environmental variables (i.e., were you breastfed as an infant, daycare
attendance as a child, having pets growing up, did you take antibiotics before age 1, were
you born via C-section, and were you born prematurely).
I employed a cross-sectional research design in this study. The cross-sectional
study design is frequently used in health promotion and when the researchers intend to
observe the health conditions at one specific time (Salazar, Crosby, & DiClemente,
2015). A cross-sectional design can be used to detect differences between patients or
phenomena, such as an exposure to a health risk or the presence of a health condition
(Salazar et al., 2015). Additionally, a cross-sectional design can be useful for assessing
the association between a risk or protective factor and a health-related outcome (Salazar
et al., 2015). A cross-sectional design was appropriate for this study because the
association between childhood SHS exposure and IBD diagnosis was evaluated.
Secondary data analysis can be used in quantitative research to gain knowledge
regarding a similar yet unique topic for which the data were initially gathered (USC
Libraries, 2019). I conducted a secondary data analysis in this study using data from the
IBDMDB. Using secondary data for this study allowed me to review data already
collected from patients with an IBD diagnosis. Use of this secondary data also supported
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the examination of data from individuals of all ages and provided access to additional
variables that may have been more difficult to collect. Using a cross-sectional design
allowed me to investigate the relationship between childhood SHS exposure and disease
diagnosis and possibly aid in the foundation of future intricate and complex studies (see
Salazar et al., 2015).
Methodology
Population
The target population for this study was children and adults of all ages with and
without an IBD diagnosis who were or were not exposed to SHS during childhood. I
retrieved the data for this study from the IBDMDB. All races, sexes, and ages were
accepted as participants, but these variables were controlled for within the statistical
analysis along with other covariates.
Sampling and Sampling Procedures
I used a convenience sample sampling strategy in this study. Since the data were
collected from a preexisting database, there was a limit to the amount of data from
patients that could be gathered. This made a convenience sampling strategy appropriate
for this study. Inclusion and exclusion factors determined the exact data that were able to
be used from this database for this study.
Data from IBDMDB consists of 5,333 entries (some are duplicates). Inclusion
and exclusion factors considerably lowered this number to 74 participants for this study.
Inclusion criteria included the following: a response to a diagnosis of IBD (i.e., CD, UC,
or non-IBD) and an answer to the question, “Were you exposed to cigarette smoke as a
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child?” Additionally, age at diagnosis was an inclusion criterion for those individuals
diagnosed with CD or UC. Individuals with a diagnosis of non-IBD but not an age at
diagnosis were still included in analysis related to RQ1 (but not to RQ2). Exclusion
criteria were nonresponses to the disease diagnosis and childhood SHS exposure
variables. I also considered a nonresponse to age at diagnosis an exclusion factor for
those individuals with UC or CD.
I performed a power analysis to determine the desired sample size for this study
using G*Power Version 3.1.9.2. The selected parameters used to calculate the sample
size were as follows: a power of 0.80 (80%), an alpha level of 0.05, and an odds ratio of
2.48. Given these parameters, the desired sample size for a two-tailed logistic regression
test was 71. A power of 80% was chosen because this is a standard level of power used;
also, 80% power means that there was an 80% probability that I would not commit a
Type II error or fail to reject the null hypothesis when it should be rejected (see Statistics
Solutions, 2019). An alpha level of 0.05 was chosen because this is the most commonly
used alpha level; this means that there was a 5% chance of making a Type I error or
rejecting the null hypothesis when I should have failed to reject the null hypothesis. I
used an odds ratio of 2.48 because this is suggested as an appropriate odds ratio to obtain
a large effect size for logistic regression (see Statistics Solutions, n.d.).
Archival Data
The data for this study came from IBDMDB. This database was formed by
collecting data from the following established longitudinal cohorts: The Prospective
Registry in IBD Study at Massachusetts General Hospital, The Pediatric Inception Cohort

36
at Cincinnati Children’s Hospital and Emory University, The Mucosal-Luminal Interface
(MLI) Cohort at Cedars-Sinai Medical Center, and The Swedish Twins (i.e., the Swedish
Twin Cohort and Swedish Longitudinal Cohort). The Prospective Registry in IBD Study
at Massachusetts General Hospital is a cohort within the Crohn’s and Colitis Center at
Massachusetts General Hospital that continually enrolls patients who are referred by their
physicians; this cohort was used to recruit 24 adults (over the age of 18 years old) who
were newly diagnosed with IBD and not familiar with treatments and six age-matched
healthy controls into the IBDMDB (n.d.). The Pediatric Inception Cohort is a cohort that
comes from the Crohn’s and Colitis Foundation RISK study, which recruits pediatric
patients with suspected IBD prior to colonoscopic examination and therapy; this cohort
was used to recruit 24 children who were newly diagnosed with IBD and not familiar
with treatments and six age-matched healthy controls (IBDMDB, n.d.). The MLI cohort
is a cohort at the Cedars-Sinai IBD Center, which recruits patients who are about to
undergo a clinically-indicated endoscopy; this cohort was used to recruit 24 adults who
had been diagnosed with IBD more than 5 years before enrollment in the MLI cohort and
six age-matched healthy controls (IBDMDB, n.d.). The Swedish Twin Cohort recruited
twins of the same sex aged 18 years or older to use as a basis for proving the IBDMDB’s
principle, and the Swedish Longitudinal Cohort recruited both men and women (not
pregnant or breastfeeding) with IBD; it was not stated how much data were gathered from
these cohorts to use as a baseline (IBDMDB, n.d.).
I was able to access the database through the IBDMDB website (ibdmdb.org). I
was then be able to click the “Download Data” link, which led me to the Results page
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where I was able to download the data in an Excel sheet. This data are publicly available,
so permission to access the data was not needed. Because the National Institutes of
Health compiled this database, I considered the data to be reputable.
Data Analysis Plan
The software program I used for the statistical analysis in this study was IBM
Statistical Package for the Social Sciences (SPSS) Statistics 25. SPSS was used to
conduct multinomial logistic regression to assess the relationship between childhood SHS
exposure (i.e., the independent variable) and the development of IBD (i.e., a dependent
variable). SPSS was also used to conduct multinomial logistic regression to assess the
relationship between childhood SHS exposure (i.e., the independent variable) and age at
diagnosis (i.e., a dependent variable) for those with IBD.
Because I used a secondary data set for this study, some data cleaning and
screening was needed. After the inclusion and exclusion factors were used to narrow
down the data set, additional cleaning and screening were needed because there were
multiple entries for the same patients (at different visits), so it looked like there were a
greater number of patients than there was. Removing these duplicate entries was
important because they would have provided duplicate data points and would have
skewed the results. In addition, all missing data were coded as 999 in order for SPSS to
be able to recognize this data as such.
The research questions and hypotheses for this study were:
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RQ1: What is the association between childhood SHS exposure and the
development of IBD after controlling for demographic (i.e., sex and race),
genetic, and environmental factors?
H01: There is no statistically significant association between childhood
SHS exposure and the development of IBD after controlling for
demographic, genetic, and environmental factors.
Ha1: There is a statistically significant association between childhood SHS
exposure and the development of IBD after controlling for demographic,
genetic, and environmental factors.
RQ2: What is the association between childhood SHS exposure and the age at
diagnosis for those who have IBD after controlling for demographic (i.e., sex and
race), genetic, and environmental factors?
H02: There is no statistically significant association between childhood
SHS exposure and the age at diagnosis for those who have IBD after
controlling for demographic, genetic, and environmental factors.
Ha2: There is a statistically significant association between childhood SHS
exposure and the age at diagnosis for those who have IBD after controlling
for demographic, genetic, and environmental factors.
I performed descriptive statistics to define the characteristics of the sample.
Frequencies and percentages were reported for categorical variables. All variables,
including covariates, were categorical in this study. Childhood SHS exposure was
defined as the individual being exposed to cigarette smoke as a child. I defined disease
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diagnosis as the individual being diagnosed with UC, CD, or non-IBD. Age at diagnosis
was the age at which the individuals with UC or CD were diagnosed. Sex was defined as
an individual being male or female. I defined race as the race of an individual.
Relatives’ disease diagnosis was defined as having a relative (i.e., parent, sibling,
grandparent, or distant relative) with IBD. I defined breastfed as an infant as an
individual being breastfed as an infant. Daycare attendance was defined as an individual
attending daycare as a child, while having pets growing up was defined as an individual
growing up with a pet or not. I defined born via C-section as an individual being born via
C-section or not and born prematurely as an individual being born prematurely.
Antibiotics before the age of 1 was defined as being treated with antibiotics before the
age of 1. These covariates have been researched in the literature and were shown to have
some type of association with the development of IBD; therefore, it was important to
have these variables as covariates to account for any interactions.
The statistical analysis test in this study included multinomial logistic regression
analysis to evaluate the potential association between variables. For example, exposure
to cigarette smoke during childhood was the independent variable for both research
questions; this variable was measured on a binary scale where individuals were coded as
exposed or not exposed (i.e., not exposed = 1; exposed = 2). Disease diagnosis was the
dependent variable for RQ1; this variable was measured on a nominal scale where
individuals were coded as having CD, UC, or non-IBD (i.e., non-IBD = 0; UC = 1; CD =
2). There were several covariates as well. Sex was measured on a binary scale where
individuals were coded as male or female (i.e., male = 0; female = 1). Race was
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measured on a binary scale where individuals were coded as White or Other (Black, more
than one race, or other; i.e., White = 0; Other = 1); race had to be coded this way in order
to include this variable in the analysis as it resulted in zeros in the crosstabulations when
broken down further. Relatives’ IBD status was measured on a binary scale where the
relatives' disease status was coded as non-IBD or IBD (i.e., non-IBD = 0; IBD = 1).
Breastfed as an infant was measured on a binary scale as being breastfed or not was
coded (i.e., no = 1; yes = 2). Daycare attendance was measured on a binary scale as
attending daycare as a child or not was coded (i.e., no = 1; yes = 2). Having pets growing
up was measured on a binary scale as having a pet during childhood or not was coded
(i.e., no = 1; yes = 2). Born via C-section was measured on a binary scale as being born
via C-section or not was coded (i.e., no = 1; yes = 2). Born prematurely was measured on
a binary scale as being born prematurely or not was coded (i.e., no = 1; yes = 2).
Antibiotic treatment was measured on a binary scale as being treated with antibiotics
before the age of 1 or not was coded (i.e., no = 1, yes = 2). All of these covariates were
included in RQ1 except born via C-section as a crosstabulation with the independent
variable resulted in zeros in some categories.
For RQ2, multinomial logistic regression was also conducted. Childhood SHS
exposure was the independent variable measured on a binary scale as in RQ1. Age at
diagnosis was the dependent variable measured on a nominal scale where individuals
were coded into age groups based on the Montreal classification (i.e., 16 years or younger
= 0; 17 to 40 years = 1; older than 40 years = 2). The covariates for RQ2 were sex,
relatives’ disease status, having pets growing up, born via C-section, and born
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prematurely; the following variables were not included in RQ2 due to the
crosstabulations resulting in zero individuals in some categories: race, breastfed as an
infant, daycare attendance, and antibiotics before the age of 1.
The results were interpreted based on the odds ratios and p values calculated by
SPSS.
Threats to Validity
External Validity
External validity involves the generalizability of the results of the study to the
general population (San José State University, n.d.). The four main types of threats to
external validity are selection biases; constructs, methods, and confounding; the real
world versus the experimental world; and history effects and maturation (Laerd
Dissertation, 2012b). In this study, selection bias could be a potential threat to external
validity. Selection bias occurs when the sample in the study is not representative of the
population (Laerd Dissertation, 2012b; San José State University, n.d). Selection bias
can usually be prevented through random assignment of participants to groups (Laerd
Dissertation, 2012b). However, this was not possible with this secondary data analysis as
the participants have already been placed into their designated groups (Laerd
Dissertation, 2012b). Selection bias was addressed by not limiting the sample to any one
race or age to provide the best chance at having a representative sample (San José State
University, n.d.). However, there was not much that could be done to prevent selection
bias since a convenience sample was used for this study.
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Internal Validity
Internal validity involves the conclusion from the research being an accurate
portrayal of the association being studied (Laerd Dissertation, 2012c). Internal validity is
also concerned with anything other than the independent variable that might affect the
dependent variable from within the study (Western Oregon University, n.d.). The 14
main types of internal validity threats are history effects, maturation, testing effects,
instrumentation, statistical regression, selection biases, experimental mortality, causal
time order, diffusion (or imitation) of treatments, compensation, compensation rivalry,
demoralization, experimenter effects, and subject effects (Laerd Dissertation, 2012c).
As with external validity, selection bias can also affect internal validity.
However, as this study uses secondary data, the groups are already chosen; therefore, the
random allocation of individuals was not possible. Causal time order may also be a threat
to internal validity for this study as it was assumed that childhood SHS exposure occurred
before the development of IBD. However, some of the data in the secondary data set
were obtained by individuals who were diagnosed with IBD during childhood, so it is
unclear if the SHS exposure occurred before, during, or after diagnosis. Therefore, for
these individuals, it was difficult to ascertain whether the independent variable (i.e.,
childhood SHS exposure) preceded the dependent variable (i.e., IBD diagnosis; Laerd
Dissertation, 2012c).
Construct Validity
Construct validity deals with making sure the measurement procedure that is used
to measure the construct is valid (Laerd Dissertation, 2012a). The threats to construct
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validity are inexact definitions of constructs, mono-operation bias, reducing levels of
measurements of constructs, mono-method bias, treatment-sensitive factorial structure,
and construct confounding (Laerd Dissertation, 2012a).
A potential threat to construct validity for this study was inexact definitions of
constructs. This threat can be present if the definitions of constructs are too broad (not
specific enough) or not completely thought out (Laerd Dissertation, 2012a). This can be
reduced by having a clear and concise operationalized definition for the constructs (Laerd
Dissertation, 2012a). By having a specific construct, the researcher can be more
confident in the study and the results. Mono-operation bias could also be present in this
study as mono-operation results from only having one measure for a construct (Laerd
Dissertation, 2012a). In this study, childhood SHS exposure was measured as a nominal
variable for exposed or not exposed to SHS as a child. However, this variable/construct
could indeed be broken down even further to include additional information, such as
duration of SHS exposure and the source of the SHS exposure (i.e., cigarettes, cigars,
vaporizers). Reducing levels of measurements of constructs may also be a threat to
construct validity in this study as the construct childhood SHS exposure could be
measured more precisely if it was continuous (Laerd Dissertation, 2012a). However, as
this study uses secondary data, reducing these threats was not possible as the data set
enforces limitations that could not be overcome.
Ethical Procedures
There were not any required agreements needed to gain access to the data since
the data were publicly available. Due to the nature of this secondary data set, there was
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no human participation involved in my study, which negates the need for recruitment or
data collection procedures. The secondary data set that was used for this study consists
of de-identified participant information. There were no concerns regarding anonymity or
confidentiality as the participants’ identifying information (i.e., name, address, phone
number, birth date, etc.) were not included in the version of the data set that I was able to
access. For this study, I was the only one accessing this data; however, since it is made
publicly available, anyone with Internet access can obtain the data. No specific
protections were necessary for the data as it were de-identified, anonymous, and
confidential. I had no conflicts of interest to report. This study met Walden University’s
ethical standards; the Institutional Review Board approval number for this study is 12-1719-0372015.
Summary
In Chapter 3, I examined the appropriate research design and methods that were
used in this study. Additionally, I highlighted the aspects of the data analysis plan,
threats to validity, and ethical considerations for this study. This detailed explanation of
the methods of how this study was executed was used to determine the relationship
between childhood SHS exposure and the development of IBD. In Chapter 4, I will
discuss the data collection and results of this study.
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Chapter 4: Results
Introduction
The purpose of this study was to determine whether an association exists between
childhood SHS exposure and IBD. Smoking is known to be associated with IBD, but the
relationship between childhood SHS exposure and IBD has not been thoroughly
researched; therefore, any potential relationship is not understood. In this study, I
examined the relationship between childhood SHS exposure and IBD diagnosis as well as
the relationship between childhood SHS exposure and the age of diagnosis for those
diagnosed with IBD. The research questions and hypotheses in this study were:
RQ1: What is the association between childhood SHS exposure and the
development of IBD after controlling for demographic (i.e., sex and race),
genetic, and environmental factors?
H01: There is no statistically significant association between childhood
SHS exposure and the development of IBD after controlling for
demographic, genetic, and environmental factors.
Ha1: There is a statistically significant association between childhood SHS
exposure and the development of IBD after controlling for demographic,
genetic, and environmental factors.
RQ2: What is the association between childhood SHS exposure and the age at
diagnosis for those who have IBD after controlling for demographic (i.e., sex and
race), genetic, and environmental factors?
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H02: There is no statistically significant association between childhood
SHS exposure and the age at diagnosis for those who have IBD after
controlling for demographic, genetic, and environmental factors.
Ha2: There is a statistically significant association between childhood SHS
exposure and the age at diagnosis for those who have IBD after controlling
for demographic, genetic, and environmental factors.
In Chapter 4, I discuss the data collection process and the results of this study.
G*Power 3.1.9.2 was used to calculate the sample size of this study using a power of
80%, an alpha of 0.05, and an odds ratio of 2.48. The statistical power of 80% and the
alpha level of 0.05 were chosen because these are standard values for these parameters.
The odds ratio of 2.48 was chosen because this is the value associated with a large effect
size for logistic regression. Based on these parameters, the desired sample size for this
study was 71. With the inclusion and exclusion criteria in mind, I was able to access data
from a total of 74 individuals from the National Institutes of Health Integrative Human
Microbiome Project: The IBDMDB.
Data Collection
As mentioned above, the data for this study were collected from the National
Institutes of Health Integrative Human Microbiome Project: The IBDMDB; therefore,
there was no time frame for data collection because all of the data were present upon
accessing the data set. I first accessed this data set for statistical analysis on December
17, 2019 after receiving Institutional Review Board approval to proceed with my data
collection and statistical analysis.
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After evaluating the secondary data set, I assessed a total of 74 participants for
this study. The participants consisted of both children and adults of all ages and sexes
with an IBD diagnosis of UC, CD, or non-IBD and a SHS exposure classification of yes
or no. Any individuals who did not have an IBD diagnosis response or a response
regarding SHS exposure were excluded from the study. Additionally, any individuals
who were categorized as having UC or CD were excluded if an age at diagnosis was not
also available. A power analysis was conducted with an alpha level of 0.05, a sample
size of 74, and an odds ratio of 2.48; this resulted in the true power of this study being
0.82.
The study consisted of data from 74 individuals of all ages and of different races
and sexes. I considered these factors as covariates in the analysis to control for any
potential differences in these characteristics regarding diagnosis of IBD. Generally
speaking, IBD affects men and women equally; IBD is commonly diagnosed between the
ages of 15 and 35 years old; and IBD affects Whites more than other races, but Blacks
and Hispanics are more likely to experience extraintestinal complications than Whites
(CCF, 2014; Moran, 2017). Additional covariates were examined including genetic and
environmental factors.
Selection bias could have been present in this study because I conducted a
secondary data analysis. Selection bias occurs when the sample in the study is not
representative of the population (Laerd Dissertation, 2012b; San José State University,
n.d.). While selection bias can usually be prevented through random assignment of
participants into groups, this was not possible because the participants in the secondary
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data were already placed into their designated groups (see Laerd Dissertation, 2012b).
This threat to external validity was addressed by not limiting the sample to any one race,
ethnicity, or age to provide the best chance at having a representative sample (see San
José State University, n.d.). In this study, little could be done to prevent selection bias
since I used convenience sampling to collect the data from the secondary data set;
however, since there were no limitations placed on these demographic variables, the
sample might be more generalizable to the larger population.
Results
Descriptive Statistics
Participant characteristics. Based on the aforementioned inclusion and
exclusion criteria, all participants were children and adults of all ages with and without an
IBD diagnosis who were or were not exposed to SHS during childhood. I performed
descriptive statistics for the continuous variable age at consent (not used in analysis). For
age of consent, the minimum was six years old, the maximum was 76 years old, the mean
25.82 years old, the median was 16.00 years old, and the standard deviation was 18.227
years old.
Frequencies and percentages for age at consent. Out of 74 participants ranging
from ages of 6 to 76 years old, 16 years old was the most common age at consent with
eight participants (10.8%) being this age. The second most common age at consent was
15 years old with seven participants (9.5%) being this age when consenting occurred.
The frequency for age at consent is presented in Table 1.
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Table 1
Frequency for Age at Consent

Valid

6
7
8
9
10
11
12
13
14
15
16
17
19
21
22
23
24
26
29
30
32
37
38
40
41
43
44
45
46
50
51
55
56
57

Frequency
2
1
2
2
3
4
2
4
4
7
8
3
1
1
1
1
1
2
1
2
1
2
1
1
1
1
1
1
1
1
2
1
1
1

Percent
2.7
1.4
2.7
2.7
4.1
5.4
2.7
5.4
5.4
9.5
10.8
4.1
1.4
1.4
1.4
1.4
1.4
2.7
1.4
2.7
1.4
2.7
1.4
1.4
1.4
1.4
1.4
1.4
1.4
1.4
2.7
1.4
1.4
1.4
(table continues)

50

60
61
62
74
76
Total

Frequency
1
1
2
1
1
74

Percent
1.4
1.4
2.7
1.4
1.4
100.0

Frequencies and percentages for disease diagnosis. Out of 74 participants, 19
participants (25.7%) were diagnosed with UC, 35 participants (47.3%) were diagnosed
with CD, and 20 participants (27.0%) were not diagnosed with IBD.
Frequencies and percentages for continuous age at diagnosis. Out of 74
participants, 54 participants (73.0%) were diagnosed with IBD with the age at diagnosis
ranging from 5 to 74 years old. The most common age at diagnosis was 16 years with
seven participants (9.5%) being diagnosed with IBD at that age. The 20 missing values
represent the participants who were not diagnosed with IBD (i.e., non-IBD), so there is
not an age at diagnosis for these participants. The frequency for continuous age at
diagnosis is presented in Table 2
Table 2
Frequency for Age at Diagnosis

Valid

5
6
7
8
9
10
11

Frequency
1
1
1
2
1
2
2

Percent
1.4
1.4
1.4
2.7
1.4
2.7
2.7
(table continues)

51

Missing
Total

12
13
14
15
16
17
19
21
22
24
25
26
28
29
30
37
41
43
45
58
74
Total
999

Frequency
2
4
3
6
7
1
1
1
1
2
1
1
1
2
5
1
1
1
1
1
1
54
20
74

Percent
2.7
5.4
4.1
8.1
9.5
1.4
1.4
1.4
1.4
2.7
1.4
1.4
1.4
2.7
6.8
1.4
1.4
1.4
1.4
1.4
1.4
73.0
27.0
100.0

Frequencies and percentages for categorical age at diagnosis. Out of the 54
participants with an IBD diagnosis, the age at diagnosis ranged from 5 to 74 years old. I
grouped the age at diagnosis into categories based on the Montreal classification. Thirtytwo participants (43.2%) were diagnosed at the age of 16 years old and younger, 17
participants (23.0%) were diagnosed between 17 to 40 years old, and five participants
(6.8%) were diagnosed at more than 40 years of age.
Frequencies and percentages for childhood secondhand smoke exposure. Out
of 74 participants, 27 participants (36.5%) were exposed to SHS during childhood, while
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47 participants (63.5%) were not exposed to SHS during childhood.
Frequencies and percentages for sex. Out of 74 participants, 38 participants
(51.4%) were male and 36 participants (48.6%) were female.
Frequencies and percentages for being breastfed as an infant. Out of 74
participants, 24 participants (32.4%) were not breastfed as an infant, 43 participants
(58.1%) were breastfed as an infant, and seven participants (9.5%) were missing this
data.
Frequencies and percentages for taking antibiotics before the age of 1. Out of
74 participants, 16 participants (21.6%) did not take antibiotics before the age of 1, 22
participants (29.7%) did take antibiotics before the age of 1, and 36 participants (48.6%)
were missing this data.
Frequencies and percentages for being born prematurely. Out of 74
participants, 59 participants (79.7%) were not born prematurely, nine participants
(12.2%) were born prematurely, and six participants (8.1%) were missing this data.
Frequencies and percentages for race. Out of 74 participants, 67 participants
(90.5%) were White, and seven (9.5%) were considered non-White (Black or African
American, more than one race, other).
Frequencies and percentages for relative’s disease diagnosis. Out of 74
participants, 53 participants (71.6%) did not have relatives with IBD, 19 participants
(25.7%) did have relatives with IBD, and two participants (2.7%) were missing this data.
Frequencies and percentages for having pets growing up. Out of 74
participants, 21 participants (28.4%) did not have pets growing up, 52 participants
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(70.3%) did have pets growing up, and one participant (1.4%) was missing this data.
Frequencies and percentages for daycare attendance as a child. Out of 74
participants, 43 participants (58.1%) did not attend daycare as a child, 30 participants
(40.5%) did attend daycare as a child, and one participant (1.4%) was missing this data.
Frequencies and percentages for born via C-section. Out of 74 participants, 59
participants (79.7%) were not born via C-section, 13 participants (17.6%) were born via
C-section, and two participants (2.7%) were missing this data.
Crosstabulations for Research Question 1
A crosstabulation was performed for the dependent variable (i.e., disease
diagnosis) and each independent variable. Regarding the entire study population (n =
74), it was determined that 47 participants were not exposed to SHS during childhood (12
non-IBD, 12 with UC, 23 with CD) and 27 participants were exposed to SHS during
childhood (eight non-IBD, seven with UC, 12 with CD). The majority of the participants
were not exposed to SHS during childhood.
Regarding the entire study population (n = 74), it was determined that 38
participants were male (10 non-IBD, eight with UC, 20 with CD) and 36 participants
were female (10 non-IBD, 11 with UC, 15 with CD). Overall, there was an equal
distribution of males and females.
Regarding the entire study population (n = 74), it was determined that 24
participants were not breastfed as an infant (nine non-IBD, four with UC, 11 with CD),
43 participants were breastfed as an infant (nine non-IBD, 14 with UC, 20 with CD), and
seven participants were missing this data. The majority of the participants were breastfed
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as an infant.
Regarding the entire study population (n = 74), it was determined that 16
participants were not given antibiotics before the age of 1 (four non-IBD, eight with UC,
four with CD), 22 participants were given antibiotics before the age of 1 (six non-IBD,
two with UC, 14 with CD), and 36 participants were missing this data. The majority of
the participants were given antibiotics before the age of 1.
Regarding the entire study population (n = 74), it was determined that 59
participants were not born prematurely (14 non-IBD, 17 with UC, 28 with CD), nine
participants were born prematurely (four non-IBD, one with UC, four with CD). The
majority of the participants were not born prematurely.
Regarding the entire study population (n = 74), it was determined that 67
participants were White (19 non-IBD, 16 with UC, 32 with CD) and seven participants
were non-White (one non-IBD, three with UC, three with CD). The majority of the
participants were White.
Regarding the entire study population (n = 74), it was determined that 53
participants did not have relatives with an IBD diagnosis (16 non-IBD, 15 with UC, 22
with CD), 19 participants did have relatives with an IBD diagnosis (four non-IBD, three
with UC, 12 with CD), and two participants were missing this data. The majority of the
participants did not have a relative with an IBD diagnosis.
Regarding the entire study population (n = 74), it was determined that 21
participants did not have pets growing up (five non-IBD, three with UC, 13 with CD), 52
participants did have pets growing up (15 non-IBD, 16 with UC, 21 with CD), and one
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participant was missing this data. The majority of the participants did have pets growing
up.
Regarding the entire study population (n = 74), it was determined that 43
participants did not attend daycare as a child (15 non-IBD, 11 with UC, 17 with CD), 30
participants did attend daycare as a child (five non-IBD, eight with UC, 17 with CD), and
one participant was missing this data. The majority of the participants did not attend
daycare as a child.
Childhood SHS Exposure and IBD Development
A multinomial logistic regression analysis was conducted to examine the potential
association between the independent variable (i.e., childhood SHS exposure) and the
dependent variable (i.e., IBD diagnosis) while controlling for the potential effects of
demographic (i.e., sex and race), genetic, and environmental variables. The covariates
for RQ1 were sex, race, relatives’ disease diagnosis, breastfed as an infant, daycare
attendance, having pets growing up, born prematurely, and antibiotics before the age of 1;
the following variable was not included in RQ1 due to the crosstabulations resulting in
zero individuals in some categories: born via C-section.
Table 3 contains the model fitting information which compares the overall model
(i.e., including all predictors/independent variables) to the null model (i.e., does not
include any predictors). A p value of less than or equal to 0.05 is statistically significant
which represents that the overall model is a better fit for the data when compared to the
null model whereas a p value greater than 0.05 is nonsignificant which indicates that the
final model is not a better fit for the data when compared to the null model. The p value
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of 0.666 is not significant at the 0.05 level, which means that the overall model is not a
significant improvement in fit compared to the null model.
Table 3
Model Fitting Information

Model
Intercept only
Final

Model Fitting
Criteria
Likelihood Ratio Tests
-2 Log
Likelihood Chi-Square
Df
Sig.
64.972
50.026
14.946
18
.666

Table 4 shows whether the model is a good fit for the data. A p value of less than
or equal to 0.05 is statistically significant which means that the model does not fit the
data well, whereas a p value greater than 0.05 is nonsignificant which means that the
model does fit the data well. The Pearson chi-square value of 0.022 is statistically
significant and indicates that the model does not fit the data well. However, the deviance
chi-square value of 0.144 is nonsignificant and indicates that the model does fit the data
well. Due to the conflicting results of the goodness of fit tests, it is difficult to determine
if the model actually fits the data or not.
Table 4
Goodness-of-Fit

Pearson
Deviance

Chi-Square
57.485
47.253

Df
38
38

Sig.
.022
.144

The Cox and Snell pseudo R-square value of 0.373 means that 37.3% of the
variability in the dependent variable (i.e., disease diagnosis) can be explained (i.e., is
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accounted for) by the independent variable (i.e., childhood SHS exposure). The
Nagelkerke pseudo R-square value of 0.424 means that 42.4% of the variability in the
dependent variable (i.e., disease diagnosis) can be explained (i.e., is accounted for) by the
independent variable (i.e., childhood SHS exposure). The McFadden pseudo R-square
value of 0.221 means that 22.1% of the variability in the dependent variable (i.e., disease
diagnosis) can be explained (i.e., is accounted for) by the independent variable (i.e.,
childhood SHS exposure).
In Table 5, the likelihood ratio tests test the contribution of each independent
variable to the overall model. The variable antibiotics before the age of 1 is the only
statistically significant independent variable for this model with a p value of 0.048. All
other independent variables are nonsignificant at the 0.05 significance level.
Table 5
Likelihood Ratio Tests
Model Fitting
Criteria
Likelihood Ratio Tests
-2 Log
Likelihood of
Reduced
Effect
Model
Chi-Square
Df
Sig.
a
Intercept
50.026
.000
0
.
Childhood SHS exposure
51.373
1.348
2
.510
Sex
50.551
.525
2
.769
Breastfed as infant
50.213
.187
2
.911
Antibiotics before age 1
56.090
6.064
2
.048
Born prematurely
52.127
2.101
2
.350
Race
50.031
.006
2
.997
Relatives’ disease
50.327
.301
2
.860
diagnosis
(table continues)
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Have pets growing up

Model Fitting
Criteria
Likelihood Ratio Tests
-2 Log
Likelihood of
Reduced
Model
Chi-Square
Df
Sig.
51.333
1.308
2
.520

Daycare attendance
50.368
.342
2
.843
Note. The chi-square statistic is the difference in -2 log-likelihoods
between the final model and a reduced model. The reduced model is
formed by omitting an effect from the final model. The null hypothesis
is that all parameters of that effect are 0.
a.
This reduced model is equivalent to the final model because omitting
the effect does not increase the degrees of freedom.
Table 6 compared each of the UC and CD diagnoses to the reference group (i.e.,
non-IBD) for each independent variable. None of the independent variables were
statistically significant for the comparison between UC and non-IBD; likewise, none of
the independent variables were statistically significant for the comparison between CD
and non-IBD.
Table 6
Parameter Estimates

a

Std.
B
Error Wald
-2.066 5.831 .125
.590 1.448 .166

Disease Diagnosis
Ulcerative Intercept
colitis
Daycare
attendance
Childhood SHS .269 1.712 .025
exposure

df
1
1

95% Confidence
Interval for
Exp(B)
Lower Upper
Sig. Exp(B) Bound Bound
.723
.684 1.804
.106
30.788

1

.875

1.309

.046

37.483

(table continues)
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Std.
Disease Diagnosisa
B
Error
Born
-1.605 1.555
prematurely
Breastfed as
.719 1.702
infant
Antibiotics
-.971 1.262
before age 1
Relatives'
-.205 1.690
disease
diagnosis
Race
.145 2.216
Sex
.974 1.432
Have pets
1.367 1.620
growing up
Crohn's Intercept
-1.817 4.781
disease
Daycare
-.143 1.201
attendance
Childhood SHS 1.501 1.525
exposure
Born
-1.790 1.478
prematurely
Breastfed as
.332 1.206
infant
Antibiotics
1.653 1.149
before age 1
Relatives'
.499 1.254
disease
diagnosis
Race
.122 2.006
Sex
.214 1.180
Have pets
-.286 1.308
growing up
a.
The reference category is: non-IBD.

Wald
1.066

df
1

95% Confidence
Interval for
Exp(B)
Lower Upper
Sig. Exp(B) Bound Bound
.302 .201
.010
4.229

.178

1

.673

2.052

.073

57.632

.592

1

.442

.379

.032

4.492

.015

1

.903

.815

.030

22.346

.004
.463
.712

1
1
1

.948
.496
.399

1.157
2.649
3.923

.015
.160
.164

89.041
43.852
93.913

.144
.014

1
1

.704
.906

.867

.082

9.127

.969

1

.325

4.487

.226

89.153

1.467

1

.226

.167

.009

3.023

.076

1

.783

1.394

.131

14.828

2.069

1

.150

5.224

.549

49.709

.158

1

.691

1.646

.141

19.236

.004
.033
.048

1
1
1

.951
.856
.827

1.130
1.238
.751

.022
.123
.058

57.569
12.510
9.756

Table 7 shows the predictive ability of the model for each diagnosis group. The
diagnosis of non-IBD was predicted by the model 37.5% of the time. The diagnosis of
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UC was predicted by the model 66.7% of the time. The diagnosis of CD was predicted
73.3% of the time. The overall predictive ability was 62.5%.
Table 7
Classification

Observed
non-IBD
Ulcerative colitis
Crohn's disease
Overall percentage

non-IBD
3
1
2
18.8%

Predicted
ulcerative
Crohn's
colitis
disease
2
3
6
2
2
11
31.3%
50.0%

Percent
Correct
37.5%
66.7%
73.3%
62.5%

Crosstabulations for Research Question 2
A crosstabulation was performed for the dependent variable (i.e., age at diagnosis)
and each independent variable. Regarding the participants who were diagnosed with IBD
(n = 54), it was determined that at the time of diagnosis 32 participants were aged 16
years or younger (10 with UC, 22 with CD), 17 participants were diagnosed between the
ages of 17 and 40 years (seven with UC, 10 with CD), and five participants were
diagnosed at more than 40 years of age (two with UC, three with CD). The majority of
the participants were diagnosed at 16 years of age or younger.
Regarding the participants who were diagnosed with IBD (n = 54), it was
determined that 35 participants were not exposed to SHS exposure during childhood (21
aged 16 years and younger, 11 aged 17 to 40 years, and three aged more than 40 years)
and 19 participants were exposed to SHS exposure during childhood (11 aged 16 years
and younger, six aged 17 to 40 years, and two aged more than 40 years). The majority of
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the participants were not exposed to SHS exposure during childhood.
Regarding the participants who were diagnosed with IBD (n = 54), it was
determined that 45 participants were not born prematurely (29 aged 16 years and
younger, 12 aged 17 to 40 years, and four aged more than 40 years), five participants
were born prematurely (one aged 16 years and younger, three aged 17 to 40 years, and
one aged more than 40 years), and four participants were missing this data. The majority
of the participants were not born prematurely.
Regarding the participants who were diagnosed with IBD (n = 54), it was
determined that 43 participants were not born via C-section (25 aged 16 years and
younger, 14 aged 17 to 40 years, and four aged more than 40 years), nine participants
were born via C-section (five aged 16 years and younger, three aged 17 to 40 years, and
one aged more than 40 years), and two participants were missing this data. The majority
of the participants were not born via C-section.
Regarding the participants who were diagnosed with IBD (n = 54), it was
determined that 16 participants did not have pets growing up (11 aged 16 years and
younger, four aged 17 to 40 years, and one aged more than 40 years), 37 participants did
have pets growing up (21 aged 16 years and younger, 13 aged 17 to 40 years, and three
aged more than 40 years), and one participant was missing this data. The majority of the
participants did have pets growing up.
Regarding the participants who were diagnosed with IBD (n = 54), it was
determined that 37 participants did not have relatives with IBD (22 aged 16 years and
younger, 11 aged 17 to 40 years, and four aged more than 40 years), 15 participants did
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have relatives with IBD (nine aged 16 years and younger, five aged 17 to 40 years, and
one aged more than 40 years), and two participants who were missing this data. The
majority of the participants did not have relatives with IBD.
Regarding the participants who were diagnosed with IBD (n = 54), it was
determined that 28 participants were male (20 aged 16 years and younger, five aged 17 to
40 years, and three aged more than 40 years) and 26 participants were female (12 aged 16
years and younger, 12 aged 17 to 40 years, and two aged more than 40 years). About half
of the participants were male and about half of the participants were female.
Childhood SHS Exposure and Age at Diagnosis for Individuals Diagnosed with IBD
A multinomial logistic regression analysis was conducted to examine the potential
association between the independent variable (i.e., childhood SHS exposure) and the
dependent variable (i.e., age at diagnosis) for those individuals diagnosed with IBD
development while controlling for the potential effects of demographic (i.e., sex and
race), genetic, and environmental variables. The covariates for RQ2 were sex, relatives’
disease status, having pets growing up, born via C-section, and born prematurely; the
following variables were not included in RQ2 due to the crosstabulations resulting in zero
individuals in some categories: race, breastfed as an infant, daycare attendance, and
antibiotics before the age of 1.
Table 8 contains the model fitting information which compares the overall model
(i.e., including all predictors/independent variables) to the null model (i.e., does not
include any predictors). A p value of less than or equal to 0.05 is statistically significant
which represents that the overall model is a better fit for the data when compared to the
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null model whereas a p value greater than 0.05 is nonsignificant which indicates that the
final model is not a better fit for the data when compared to the null model. The p value
of 0.560 is not significant at the 0.05 level, which means that the overall model is not a
significant improvement in fit compared to the null model.
Table 8
Model Fitting Information

Model
Intercept only
Final

Model Fitting
Criteria
Likelihood Ratio Tests
-2 Log
Likelihood Chi-Square
Df
Sig.
60.476
49.834
10.642
12
.560

Table 9 shows whether the model is a good fit for the data. A p value of less than
or equal to 0.05 is statistically significant which means that the model does not fit the
data well, whereas a p value greater than 0.05 is nonsignificant which means that the
model does fit the data well. The Pearson chi-square value of 0.110 is nonsignificant and
indicates that the model fits the data well. The deviance chi-square value of 0.158 is also
nonsignificant and indicates that the model fits the data well.
Table 9
Goodness-of-Fit

Pearson
Deviance

Chi-Square
39.733
37.678

Df
30
30

Sig.
.110
.158

The Cox and Snell pseudo R-square value of 0.207 means that 20.7% of the
variability in the dependent variable (i.e., age at diagnosis) can be explained by the
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independent variable (i.e., childhood SHS exposure). The Nagelkerke pseudo R-square
value of 0.250 means that 25.0% of the variability in the dependent variable (i.e., age at
diagnosis) can be explained by the independent variable (i.e., childhood SHS exposure).
The McFadden pseudo R-square value of 0.132 means that 13.2% of the variability in the
dependent variable (i.e., age at diagnosis) can be explained by the independent variable
(i.e., childhood SHS exposure).
In Table 10, the likelihood ratio tests test the contribution of each independent
variable to the overall model. None of the independent variables are significant at the
0.05 significance level.
Table 10
Likelihood Ratio Tests
Model Fitting
Criteria
Likelihood Ratio Tests
-2 Log
Likelihood of
Reduced
Effect
Model
Chi-Square
Df
Sig.
Intercept
49.834a
.000
0
.
Childhood SHS exposure
50.381
.547
2
.761
Born prematurely
52.553
2.719
2
.257
Born via C-section
50.322
.488
2
.783
Have pets growing up
51.475
1.641
2
.440
Relatives' disease
49.959
.125
2
.939
diagnosis
Sex
54.033
4.199
2
.122
Note. The chi-square statistic is the difference in -2 log-likelihoods
between the final model and a reduced model. The reduced model is
formed by omitting an effect from the final model. The null hypothesis
is that all parameters of that effect are 0.
a.
This reduced model is equivalent to the final model because omitting
the effect does not increase the degrees of freedom.
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Table 11 compared each of the age at diagnosis groups (i.e., 17 to 40 years old
and more than 40 years old) to the reference group (i.e., 16 years old and younger) for
each independent variable. None of the independent variables were statistically
significant for the comparison between the 17 to 40 years old group and the 16 years old
and younger group; likewise, none of the independent variables were statistically
significant for the comparison between the over 40 years old group and the 16 years old
and younger group.
Table 11
Parameter Estimates

Age at Diagnosis
(categorical)a
17 to 40 Intercept
years
Childhood SHS
exposure
Born prematurely
Born via Csection
Have pets
growing up
Relatives’ disease
diagnosis
Sex
more than Intercept
40 years Childhood SHS
exposure
Born prematurely
Born via Csection

95% Confidence
Interval for Exp(B)
Std.
Lower
Upper
B Error Wald df Sig. Exp(B) Bound
Bound
-5.333 2.788 3.658 1 .056
.286 .784 .133 1 .715 1.332
.286
6.195
1.810 1.323 1.870 1 .171 6.108
-.632 1.115 .322 1 .571 .531

.457
.060

81.695
4.725

1.148 .951 1.458 1 .227 3.152

.489

20.322

.319

.930 .118 1 .732 1.376

.222

8.510

1.591 .821 3.755 1 .053 4.911
-6.452 3.749 2.962 1 .085
.846 1.190 .506 1 .477 2.331

.982

24.559

.226

24.016

2.089 1.689 1.530 1 .216 8.077
.286 1.524 .035 1 .851 1.331

.295
.067

221.224
26.364

(table continues)
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Have pets
growing up

95% Confidence
Interval for Exp(B)
Std.
Lower
Upper
B Error Wald df Sig. Exp(B) Bound
Bound
.286 1.299 .049 1 .826 1.331
.104
16.982

Relatives' disease .208 1.396 .022 1 .882 1.231
diagnosis
Sex
.243 1.272 .036 1 .849 1.275
a.
The reference category is: 16 years and younger.

.080

19.007

.105

15.424

Table 12 shows the predictive ability of the model for each diagnosis group. The
age at diagnosis of 16 years and younger was predicted by the model 82.1% of the time.
The age at diagnosis of 17 to 40 years was predicted by the model 64.3% of the time.
The age at diagnosis of more than 40 years was predicted by the model 0.0% of the time.
The overall predictive ability was 69.6%.
Table 12
Classification

Observed
16 years and younger
17 to 40 years
more than 40 years
Overall percentage

Predicted
16 years and
more than 40
younger
17 to 40 years
years
23
5
0
5
9
0
2
2
0
65.2%
34.8%
0.0%

Percent
Correct
82.1%
64.3%
0.0%
69.6%

Summary
The purpose of this study was to examine the potential relationship between
childhood SHS exposure and IBD diagnosis while controlling for demographic, genetic,
and environmental covariates. Additionally, this study also investigated the potential
relationship between childhood SHS exposure and age at diagnosis for individuals
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diagnosed with IBD while controlling for demographic, genetic, and environmental
covariates. Regarding RQ1, there was not a statistically significant association between
childhood SHS exposure and the development of IBD after controlling for demographic,
genetic, and environmental factors; I failed to reject the null hypothesis for RQ1.
Regarding RQ2, there was not a statistically significant association between childhood
SHS exposure and the age at diagnosis for those who have IBD after controlling for
demographic, genetic, and environmental factors; I failed to reject the null hypothesis for
RQ2.
The findings of this study will be considered further in Chapter 5 by comparing
the findings of this study to existing literature results. In Chapter 5, I will also discuss the
limitations of this study, recommendations for future research relative to this specific
topic, and implications of these results.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
The purpose of this study was to examine the association between childhood SHS
exposure and the development of IBD after controlling for demographic (i.e., sex and
race), genetic, and environmental covariates. In addition, I also examined the association
between childhood SHS exposure and the age of IBD diagnosis after controlling for
covariates. The covariates used were sex, race, relatives’ disease diagnosis, breastfed as
an infant, daycare attendance, having pets growing up, born via C-section, born
prematurely, and antibiotics before the age of 1.
Previous literature has shown that studies regarding the effect of smoking and
IBD have been conducted; however, research regarding SHS exposure and IBD is
limited. Examining the association between SHS exposure during childhood could
contribute to the knowledge regarding the effects of environmental factors on the
development of IBD. The findings of this study could lead to physicians learning more
about the causes of these diseases and individuals having a better understanding of their
potential risks associated with the environment.
In this study, I used a quantitative approach and a cross-sectional design to assess
the association between the independent and dependent variables. Secondary data from
the National Institutes of Health were used for this study because the data set contained
information regarding individuals with and without IBD who were or were not exposed
to SHS exposure during childhood. Multinomial logistic regression was performed for
both research questions to determine if there was an association between the independent
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and dependent variables while controlling for demographic, genetic, and environmental
covariates.
The findings of this study were not statistically significant for both research
questions. For RQ1, the overall model was not significant; however, the variable of
antibiotics before the age of 1 was found to be statistically significant when only
comparing its specific contribution to the overall model. For RQ2, none of the findings
were significant.
Interpretation of the Findings
The overall scope of the study was to examine the relationship between childhood
SHS exposure and IBD diagnosis. The sample population of this study consisted of 74
children and adults of all ages with and without an IBD diagnosis who were or were not
exposed to SHS during childhood. The first research question was: What is the
association between childhood SHS exposure and the development of IBD after
controlling for demographic (i.e., sex and race), genetic, and environmental factors? The
second research question was: What is the association between childhood SHS exposure
and the age at diagnosis for those who have IBD after controlling for demographic (i.e.,
sex and race), genetic, and environmental factors? Previous researchers had not fully
examined the potential association between childhood SHS exposure and the
development of IBD; therefore, there was limited literature that directly related to either
research question. Since the results of the multinomial logistic regression tests for both
research questions were not statistically significant, the findings of this study did not
confirm, disconfirm, or extend any previous knowledge regarding the main variables in
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both research questions; however, previous literature regarding the covariates were used
in this study.
The covariates used in this study were sex, race, relatives’ disease diagnosis,
breastfed as an infant, daycare attendance, having pets growing up, born via C-section,
born prematurely, and use of antibiotics before the age of 1. Use of antibiotics before the
age of 1 was the only independent variable that was statistically significant (p value =
0.048) in contributing to the overall model (see Table 5). This variable was significant in
contributing to the overall model; however, this variable was not statistically significant
when the groups of disease diagnosis were compared (see Table 6). Previous researchers
stated that the use of antibiotics has been associated with new cases of CD but not UC
(Ungaro et al., 2014). Future research is needed to further understand the potential
association between antibiotics and IBD development. The other covariates were also
mentioned briefly in previous literature, but the nonsignificant results of these variables
do not contribute any meaning to the literature or fill any gaps in the literature. Further
research is also needed to evaluate these variables to determine whether they are involved
in the development of IBD because there is currently only a limited amount of research
available regarding early life exposures and the development of IBD.
As stated previously, the only variable that was statistically significant (p value =
0.048) for this study was use of antibiotics before the age of 1 when examining the
contribution of each independent variable to the overall model (see Table 5). Therefore, I
can only interpret the theoretical framework in terms of use of antibiotics before the age
of 1. The theoretical framework I used in this study was Bronfenbrenner’s ecological
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systems theory, which is based on the premise that there are multiple systems in which an
individual lives and that each system contributes to the development of an individual
(The Psychology Notes Headquarter, 2013). In this interpretation, the use of antibiotics
before age 1 can be considered to be a part of the microsystem of the individual because
it directly affects the individual; the potential for the use of antibiotics before the age of 1
to have an effect on the development of the individual over time is considered part of the
chronosystem. In this context, there is an association between the use of antibiotics
before the age of 1 and the IBD diagnosis over time since the use of antibiotics before the
age of 1 is statistically significant in contributing to the overall model. However, since
the use of antibiotics before the age of 1 was not statistically significant when the
different groups of IBD diagnosis were compared, it is not possible to say exactly what
kind of association exists between the use of antibiotics before the age of 1 and IBD
diagnosis. More research is needed in the future to further explore this relationship.
Additionally, more research is also needed to further explore the potential for an
association between IBD diagnosis and other environmental factors.
Limitations of the Study
I identified several limitations in this study. The first limitation was the use of a
secondary data set to perform the analyses needed to answer the research questions. This
is considered a limitation for a couple of reasons. First, the secondary data set was not
originally collected for the purposes of this study, so the data were not intended to answer
the research questions posed in this study (see Cheng & Phillips, 2014). Second, because
I was not involved with the data collection process, there might be additional aspects of
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the data that I could not account for regarding the variables (see Cheng & Phillips, 2014).
For example, the variable childhood SHS exposure was my main independent variable;
however, the variable is vague, and I cannot know if the participants who were diagnosed
as children were exposed to SHS before, during, or after being diagnosed; this could lead
to some complications if I was trying to determine causation rather than correlation.
Another limitation of this study was the small sample size, which could have
affected the results of the study in several ways. A small sample size decreases the
generalizability of the extrapolation of the findings; this is the same as saying that the
sample is not representative of the population (Faber & Fonseca, 2014). Studies with
small samples may not yield reliable or precise results (Hackshaw, 2008). Since I was
using a secondary data set to collect data for my study, I was unable to control the sample
size. I had to use what was available in the secondary data set. The data set contained
several entries for the same patient, which led to eliminating entries of duplicates. In
addition, the inclusion and exclusion factors had to be met for a participant to be included
in this research study; these factors greatly limited the number of participants that could
be included. There were also limitations regarding the included covariates and the
potential covariates that were excluded. Race was included in the analyses, but instead of
using the predetermined groups (i.e., White, Black or African American, more than one
race, and other), the last three groups had to be combined, which resulted in only two
groups (i.e., White and Other). This recategorization was essential in order to be able to
include race at all since there were not enough participants in the remaining groups.
Ethnicity was not able to be included in the analyses due to a limited response of those
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who were Hispanic or Latino. Relatives’ disease diagnosis also had to be modified to be
able to include it in the analysis; instead of having several groups that distinctly explained
all of the possibilities, this variable had to be grouped into the participant having relatives
with IBD or the participant having relatives without IBD. There was no specification of
IBD allowed in order to include this variable of relatives’ disease diagnosis in the
analyses. However, since genetics plays a role in the development of IBD, this was a
very important variable to include (CCF, 2014; Orholm et al., 1991). The change in the
categorization of and the exclusion of these aforementioned variables from the analysis
resulted in the sample not being representative of the entire population. A larger sample
size could have potentially increased the number of usable covariates and decreased the
amount of regrouping of some variables.
Recommendations
After conducting and reviewing the results of this study, I have some
recommendations for further study. First, I recommend that research regarding IBD and
children is continually performed; the ethical issues that are evident when involving
vulnerable populations, such as children, in research can keep relevant and crucial
research from being conducted, but vulnerable populations need the most help in terms of
research results. In the literature, there has not been enough research performed that
involves children with IBD and environmental or other factors that can help determine
the causes of these diseases.
I also recommend that this research study be repeated with different samples. The
sample size (n = 74) was very small and did not allow for a proper comparison between
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the different groups of IBD diagnosis. A more diverse sample would also be beneficial
because it is important to study the differences in diseases for different races and
ethnicities in order to be able to tailor treatments or preventive measures to those
individuals who might be more susceptible to developing IBD. In addition, since the
amount of data on IBD and environmental exposures was very limited, it might be
beneficial to conduct a primary data analysis; although this would definitely be more time
consuming, the researcher would be able to play a role in the data collection process and
gain insight into any idiosyncrasies seen in the data. Repeating this study with different
samples would also be important; even if the results were statistically significant for this
study, the results can only be generalized so far, and research can only be proved with
repetition. One study is not enough to determine clarity on the relationships between
variables.
Implications
Social Change
This study, along with future related research, has the potential to have an impact
for positive social change at many levels. This study could lead to additional studies that
might examine the risk of an individual for developing IBD. Knowledge of personal
risks of disease could lead to preventative measures that might eliminate or reduce the
chance of an individual developing the disease. This research, and others like it, might
help those diagnosed with IBD because they will see that they are not alone in this fight
against the disease. Since these diseases tend to run in families, it is important to
examine the potential risk factors for individuals within the family as well. If an
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environmental factor, such as SHS, is determined to be associated with the development
of IBD, then it would be important to examine the habits (in this case, smoking) of family
members that might increase the risk for IBD for the entire family. In addition to the
individual and family levels, it is important to consider the community level, which can
focus on taking these results and transforming them into policies that may help prevent
the development of IBD and focus on increasing public health and awareness regarding
GI diseases. Furthermore, physicians can use research regarding potential risk factors to
help them better diagnose and prepare individuals for the treatment of IBD.
Theoretical Framework
As previously mentioned, the theoretical framework for this study was
Bronfenbrenner’s ecological systems theory, which has been used previously in social
work, education, psychology, policymaking, and public health (“Ecological systems
theory,” 2018). This theory suggests that the environment of an individual affects the
individual’s growth and development and that there are many different levels of an
individual’s environment that all interact together (“Ecological systems theory,” 2018).
Bronfenbrenner’s ecological systems theory was used as the framework for this study
while keeping in mind the effects that the environment, at many different levels, might
influence the health of an individual. I only examined the microsystem and the
chronosystem in this study because the microsystem consists of the individual’s direct
environment (i.e., represented by SHS exposure), and the chronosystem represents the
development over time (i.e., represented by the development of IBD; see “Ecological
systems theory,” 2018). I evaluated the potential association between childhood SHS
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exposure and IBD development with this theory as the underlying basis for how the
environment can play a role in the development of an individual.
Recommendations for Practice
The results from this study were aimed at determining an additional risk factor for
IBD development that might aid in guiding physicians regarding the prevention and
diagnosis of IBD. The findings indicated the need for additional studies in order to
increase knowledge regarding IBD and the potential associations between environmental
exposures and IBD development. The nonsignificance of these results also showed that
more work is needed to create a valuable research design. The lack of ability to gather a
meaningful sample size should lead professionals to try to find new ways to reach out to
patients and extend the pool of patients for analysis in order to be able to obtain relevant
and significant data. The statistically significant result for the use of antibiotics before
the age of 1 occurred only when comparing the effects of each variable to the overall
model. Conducting studies with a larger sample size can lead to better results because
more variables can also be evaluated without worrying about some groups having zero
frequencies, which was the major problem with this study.
Conclusion
Although there are several studies regarding IBD development, the exact causes
of IBD are unknown. Researchers believe the cause of IBD to be multifactorial and
include genetics, environmental factors, and the immune system response (CCF, 2014;
Moran, 2017). There is also a very limited amount of extant studies regarding children
and IBD. This is most likely due to ethical concerns regarding the use of children in
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research because they are vulnerable populations. While additional protections are
necessary for children in research, it is extremely important for research to be conducted
with this population in mind because their bodies are different than adults so it is
difficult, and slightly impractical, to generalize the results from adult studies to the IBD
population of children.
There are studies in the current literature that focus on the effect of smoking on
the development of IBD; however, studies regarding childhood SHS exposure are not
available. Therefore, in this study, I examined the potential association between
childhood SHS exposure and the development of IBD as well as the potential association
between childhood SHS exposure and the age of diagnosis for those individuals
diagnosed with IBD. The results of this study were nonsignificant except for when it
comes to the variable of the use of antibiotics before the age of 1, but this variable was
only statistically significant when determining its effect on the overall model.
With this study, I sought to address the gap in the literature; however, a small
sample size, the major limitation, did not allow the results to address this gap. Future
research, hopefully with a much larger sample size, could now address this gap while
steering clear of the limitations and pitfalls of this study. Even though this research
provided very limited results, it is still important because future researchers can adapt to
the complications seen in this study and use the limitations of this study to conduct
research that might lead to statistically significant results.
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